Carl I. Schwartz Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Carl I. Schwartz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Carl I. Schwartz. Carl I. Schwartz is 10% Owner in SIGMA LABS, INC. ($SGLB) and Chief Executive Officer in SIGMA LABS, INC. ($SGLB) and Chief Executive Officer in Skyline Medical Inc. ($SKLN) and Director in Skyline Medical Inc. ($SKLN).
Latest Insider Trading Transactions of Carl I. Schwartz
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Buy | J | 1.43 | 100,401 | 143,573 | 1,711,742 | 1.6 M to 1.7 M (+6.23 %) |
Oct 26 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Sell | S | 0.85 | 640 | 544 | 1,611,341 | 1.6 M to 1.6 M (-0.04 %) |
Oct 26 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Sell | S | 0.85 | 640 | 544 | 1,611,341 | 1.6 M to 1.6 M (-0.04 %) |
Oct 02 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.81 | 6,142 | 5,000 | 6,142 | |
Sep 25 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 6,050 | 9,317 | 6,050 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 5.51 | 6,050 | 33,336 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 5,128 | 7,897 | 5,128 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 6.50 | 5,128 | 33,332 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 4,219 | 6,497 | 4,219 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 7.90 | 4,219 | 33,330 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 20,000 | 30,800 | 20,000 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 7.48 | 20,000 | 149,600 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 59 | 91 | 59 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 42.50 | 59 | 2,508 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 133 | 205 | 133 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 37.50 | 133 | 4,988 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 121 | 186 | 121 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 41.25 | 121 | 4,991 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 179 | 276 | 179 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 28.00 | 179 | 5,012 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 238 | 367 | 238 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 21.00 | 238 | 4,998 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 7 | 11 | 7 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 2,812.50 | 7 | 19,688 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 32,305 | 49,750 | 32,305 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 6.19 | 32,305 | 200,000 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 4,490 | 6,915 | 4,490 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 11.60 | 4,490 | 52,084 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 12,168 | 18,739 | 12,168 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 11.30 | 12,168 | 137,498 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 14,178 | 21,834 | 14,178 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 9.70 | 14,178 | 137,527 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 2,834 | 4,364 | 2,834 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 14.70 | 2,834 | 41,660 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 37,691 | 58,044 | 37,691 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 14.70 | 37,691 | 554,058 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 714 | 1,100 | 714 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 28.00 | 714 | 19,992 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 52 | 80 | 52 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 775.00 | 52 | 40,300 | 0 | |
Jul 02 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.64 | 3,049 | 5,000 | 3,049 | |
Jun 19 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Grant | A | 0.00 | 4,070 | 0 | 1,611,981 | 1.6 M to 1.6 M (+0.25 %) |
Apr 23 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Grant | A | 1.43 | 1,533,481 | 2,192,878 | 1,607,911 | 74.4 K to 1.6 M (+2,060.30 %) |
Apr 23 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Grant | A | 1.43 | 1,533,481 | 2,192,878 | 1,607,911 | 74.4 K to 1.6 M (+2,060.30 %) |
Apr 06 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.58 | 3,174 | 5,000 | 3,174 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.55 | 60,496 | 33,333 | 60,496 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,205,923 | |
Oct 03 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,194,417 | |
Sep 18 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.55 | 60,496 | 33,333 | 60,496 | |
Sep 18 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,194,417 | |
Aug 16 2019 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | Chief Executive Off ... | Buy | P | 0.75 | 62,433 | 46,825 | 2,000,000 | 1.9 M to 2 M (+3.22 %) |
Aug 16 2019 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | Chief Executive Off ... | Buy | P | 0.69 | 437,567 | 301,921 | 1,937,567 | 1.5 M to 1.9 M (+29.17 %) |
Aug 15 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,276,387 | |
Aug 15 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.65 | 51,282 | 33,333 | 1,264,481 | |
Aug 15 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.79 | 42,194 | 33,333 | 1,213,599 | |
Jul 02 2019 | AIPT | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,171,405 | |
Jun 04 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,159,899 | |
May 28 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Buy | P | 0.55 | 48,332 | 26,689 | 244,298 | 196 K to 244.3 K (+24.66 %) |
May 28 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Buy | P | 0.56 | 51,668 | 29,099 | 195,966 | 144.3 K to 196 K (+35.81 %) |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,148,393 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 1,136,887 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 1,131,608 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 1.19 | 138,889 | 165,000 | 1,126,329 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 987,440 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 11,506 | 8,100 | 1,148,393 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 1,136,887 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 1,131,608 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 1.19 | 138,889 | 165,000 | 1,126,329 | |
May 24 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 5,279 | 3,716 | 987,440 | |
May 23 2019 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Option Exercise | P | 1.56 | 200,000 | 312,000 | 200,000 | |
May 23 2019 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 1.40 | 400,000 | 560,000 | 400,000 | 0 to 400 K |
Apr 08 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.75 | 200,000 | 149,600 | 200,000 | |
Apr 02 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 6,227 | 4,384 | 982,161 | |
Mar 04 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 6,227 | 4,384 | 975,934 | |
Feb 05 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | J | 0.70 | 6,227 | 4,384 | 969,707 | |
Jan 17 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | P | 0.70 | 742,188 | 522,500 | 963,480 | |
Jan 17 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.62 | 323,050 | 200,000 | 323,050 | |
Jan 17 2019 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Buy | P | 0.64 | 78,125 | 50,000 | 144,298 | 66.2 K to 144.3 K (+118.06 %) |
Dec 10 2018 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | P | 0.84 | 221,292 | 185,000 | 221,292 | |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 1.02 | 88,993 | 90,773 | 1,500,000 | 1.4 M to 1.5 M (+6.31 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 1.03 | 7,361 | 7,582 | 1,411,007 | 1.4 M to 1.4 M (+0.52 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 1.02 | 8,063 | 8,224 | 1,403,646 | 1.4 M to 1.4 M (+0.58 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 1.03 | 99,756 | 102,749 | 1,395,583 | 1.3 M to 1.4 M (+7.70 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 1.03 | 57,083 | 58,795 | 1,295,827 | 1.2 M to 1.3 M (+4.61 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 1.02 | 3,600 | 3,672 | 1,238,744 | 1.2 M to 1.2 M (+0.29 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.99 | 106,753 | 105,685 | 1,235,144 | 1.1 M to 1.2 M (+9.46 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.98 | 65,374 | 64,067 | 1,128,391 | 1.1 M to 1.1 M (+6.15 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.97 | 36,411 | 35,319 | 1,063,017 | 1 M to 1.1 M (+3.55 %) |
Sep 04 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.88 | 26,606 | 23,413 | 1,026,606 | 1000 K to 1 M (+2.66 %) |
Aug 27 2018 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.16 | 44,899 | 52,083 | 44,899 | |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.90 | 27,025 | 24,320 | 1,000,000 | 973 K to 1000 K (+2.78 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.90 | 33,067 | 29,618 | 972,975 | 939.9 K to 973 K (+3.52 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.85 | 100 | 85 | 939,908 | 939.8 K to 939.9 K (+0.01 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.85 | 11,900 | 10,057 | 939,808 | 927.9 K to 939.8 K (+1.28 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.85 | 6,163 | 5,218 | 927,908 | 921.7 K to 927.9 K (+0.67 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.85 | 3,745 | 3,175 | 921,745 | 918 K to 921.7 K (+0.41 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.83 | 20,400 | 16,920 | 918,000 | 897.6 K to 918 K (+2.27 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.86 | 11,900 | 10,234 | 897,600 | 885.7 K to 897.6 K (+1.34 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.85 | 18,225 | 15,464 | 885,700 | 867.5 K to 885.7 K (+2.10 %) |
Aug 08 2018 | SGLB | SIGMA LABS, INC. | Schwartz Carl I. | 10% Owner | Buy | P | 0.86 | 11,572 | 9,946 | 867,475 | 855.9 K to 867.5 K (+1.35 %) |
Jul 02 2018 | AIPT | Precision Therapeu ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.13 | 121,682 | 137,501 | 121,682 | |
Jan 04 2018 | SKLN | Skyline Medical In ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.97 | 141,753 | 137,500 | 141,753 | |
Nov 14 2017 | SKLN | Skyline Medical In ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.47 | 28,316 | 41,625 | 28,316 | |
Jun 26 2017 | SKLN | Skyline Medical In ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.47 | 376,886 | 554,022 | 376,886 | |
Apr 06 2017 | SKLN | Skyline Medical In ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 2.10 | 2,381 | 5,000 | 2,381 | |
Jan 27 2017 | SKLN | Skyline Medical In ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 2.80 | 1,786 | 5,001 | 1,786 | |
Jan 27 2017 | SKLN | Skyline Medical In ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 2.80 | 7,143 | 20,000 | 7,143 | |
Jul 07 2016 | SKLN | Skyline Medical In ... | Schwartz Carl I. | Director | Option Exercise | A | 0.15 | 33,334 | 5,000 | 33,334 | |
Apr 05 2016 | SKLN | Skyline Medical In ... | Schwartz Carl I. | Director | Option Exercise | A | 0.17 | 14,706 | 2,500 | 14,706 |
Page: 1